Abstract
Background
Autoimmune thyroid disease (ATD) patients may have a higher prevalence of anti-parietal cell antibodies (APCA) than normal population.
Objective
To study the prevalence of APCA in a cohort of ATD patients to know its association with patient’s clinical profile and gastrointestinal complaints.
Methods
APCA was sought for by indirect immunofluorescence test in 243 ATD patients: 136 (55.9%) with Graves’ disease and 107 (44.0%) with Hashimoto’s thyroiditis. A structured questionnaire for gastrointestinal symptoms, previous history of thrombosis, arthralgia and other autoimmune diseases in the patients and their families was applied. Positive and negative APCA individuals were compared. Positive patients were invited to perform upper gastrointestinal endoscopy and biopsy of duodenum segments. Sera from 100 healthy individuals from the same geographic area were used as controls.
Results
APCA was present in 20.1% (49/243) of ATD patients: 21.3% (29/136) in the Graves’ sample and 18.6% (20/107) in the Hashimoto’s sample (p = 0.61). Patients with positive APCA had more anemia (p = 0.03; OR = 2.89; 95% CI = 1.03–8.07) and less heartburn (p = 0.01; OR = 0.4; 95% CI = 0.20–0.83). Among the group of 49 APCA-positive patients, 24 agreed with upper endoscopy and it was found that 54.1% had atrophic gastritis.
Conclusions
There is a high prevalence of positive APCA in ATD patients. APCA are more common in those with anemia and less common in those with complaints of heartburn. Almost half of positive APCA patients had atrophic gastritis.
Similar content being viewed by others
References
Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR (2017) Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol 10:19–27
Rusak E, Chobot A, Krzywicka A, Wenzlau J (2016) Anti-parietal cell antibodies–diagnostic significance. Adv Med Sci 61:175–179
Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP (2014) Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol 20:613–629
Šterzl I, Hrdá P, Matucha P, Čeřovská J, Zamrazil V (2008) Anti-Helicobacter pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res 57(S1):S135–S141
Lahner E, Annibale B (2009) Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 15:5121–5128
Venerito M, Radünz M, Reschke K, Reinhold D, Frauenschläger K, Jechorek D et al (2015) Autoimmune gastritis in autoimmune thyroid disease. Aliment Pharmacol Ther 41:686–693
Cellini M, Santaguida MG, Virili C, Capriello S, Brusca N, Gargano L et al (2017) Hashimoto’s thyroiditis and autoimmune gastritis. Front Endocrinol (Lausanne) 26:8–92. doi:10.3389/fendo.2017.00092 (eCollection 2017)
Gerenova B, Manolova IM, Tzoneva VI (2013) Clinical significance of auto antibodies to parietal cells in patients with autoimmune thyroid diseases. Folia Med (Plovdiv) 55:26–32
Santaguida MG, Virili C, Del Duca SC, Cellini M, Gatto I, Brusca N, De Vito C, Gargano L, Centanni M (2015) Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49:51–57
García-García B, GimenoOrna JA, Aguillo GE, AltemirTrallero J, Cabrejas Gómez C, Ilundaín González A et al (2010) Prevalence and predictive factors of parietal cell antibody positivity in autoimmune thyroid disease. Endocrinol Nutr 57:49–53
Bigazzi PE, Rose NR (1984) Pruebas para anticuerpos contra antigenos tissulares especificos. In: Rose NR, Friedman H (eds) El laboratorio en inmunologia clínica, 2nd edn. Editorial Medica Pan Americana, Buenos Aires, pp 968–979
Neumann WL, Coss E, Rugge M, Genta RM (2013) Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol 10:529–541
Fallahi P, Ferrari SM, Ruffilli I, Elia G, Biricotti M, Vita R et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15:1125–1128
Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, DelleFave G et al (1999) Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch Intern Med 159:1726–1730
Irvine WJ, Cullen DR, Mawhinney H (1974) Natural history of autoimmune achlorhydric atrophic gastritis. A 1–15-year follow-up study. Lancet 2:482–485
Singer W, Sahay BM (1966) Myasthenia gravis, Hashimoto’s thyroiditis, and pernicious anaemia. Br Med J 1(5492):904
Park JY, Lam-Himlin D, Vemulapalli R (2013) Review of autoimmune metaplastic atrophic gastritis. Gastrointest Endosc 77:284–292
Wu YH, Chang JYF, Wang YP, Wu YC, Chen HM, Sun A (2017) Anemia and hematinic deficiencies in anti-gastric parietal cell antibody-positive and -negative recurrent aphthous stomatitis patients with anti-thyroid antibody positivity. J Formos Med Assoc 116:145–152
Oh RC, Brown DL (2003) Vitamin B12 deficiency. Am Fam Phys 67:979e86
Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L (2016) Iron deficiency anaemia. Lancet 387(10021):907–916
Wang YP, Lin HP, Chen HM, Kuo YS, Lang MJ, Sun A (2014) Hemoglobin, iron, and vitamin B12 deficiencies and high blood homocysteine levels in patients with anti-thyroid autoantibodies. J Formos Med Assoc 113:155–160
Sibilla R, Santaguida MG, Virili C, Gargano L, Nardo S, Guardia MD et al (2008) Chronic unexplained anaemia in isolated autoimmune thyroid disease or associated with autoimmune related disorders. Clin Endocrinol (Oxf) 68:640–645
Carabotti M, Lahner E, Esposito G, Sacchi MC, Severi C, Annibale B (2017) Upper gastrointestinal symptoms in autoimmune gastritis: a cross-sectional study. Medicine (Baltimore) 96:e5784
Tozzoli R, Kodermaz G, Perosa AR, Tampoia M, Zucano A, Antico A et al (2010) Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases. Autoimmun Rev 10:80–83
Yamanishi S, Iizumi T, Watanabe E, Shimizu M, Kamiya S, Nagata K et al (2006) Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74:248–256
Lahner E, Virili C, Santaguida MG, Annibale B, Centanni M (2014) Helicobacter pylori infection and drugs malabsorption. World J Gastroenterol 20:10331–10337
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This study was approved by the local Ethics Research Committee.
Informed consent
All participants signed a written consent.
Rights and permissions
About this article
Cite this article
Utiyama, S.R.R., De Bem, R.S., Skare, T.L. et al. Anti-parietal cell antibodies in patients with autoimmune thyroid diseases. J Endocrinol Invest 41, 523–529 (2018). https://doi.org/10.1007/s40618-017-0755-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0755-2